{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:11:07Z","timestamp":1793722267203,"version":"4.6.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116125","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:04:22Z","timestamp":1710248662000},"page":"116125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Securinine inhibits the tumor growth of human bladder cancer cells by suppressing Wnt\/\u03b2-catenin signaling pathway and activating p38 and JNK signaling pathways"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3300-374X","authenticated-orcid":false,"given":"Liping","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habu","family":"Jiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoji","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-1735","authenticated-orcid":false,"given":"Jinyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116125_b0005","doi-asserted-by":"crossref","unstructured":"J. Dobruch, M. Oszczud\u0142owski, Bladder Cancer: Current Challenges and Future Directions, Medicina (Kaunas) 57(8) (2021).","DOI":"10.3390\/medicina57080749"},{"issue":"3","key":"10.1016\/j.bcp.2024.116125_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2024.116125_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"10061","key":"10.1016\/j.bcp.2024.116125_b0020","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet (london, England)"},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bcp.2024.116125_b0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur. Urol."},{"issue":"7986","key":"10.1016\/j.bcp.2024.116125_b0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/d41586-023-03421-8","article-title":"Cancer trial results show power of weaponized antibodies","volume":"623","author":"Ledford","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116125_b0040","doi-asserted-by":"crossref","unstructured":"J.A. Witjes, H.M. Bruins, R. Cathomas, E.M. Comp\u00e9rat, N.C. Cowan, G. Gakis, V. Hern\u00e1ndez, E. Linares Espin\u00f3s, A. Lorch, Y. Neuzillet, M. Rouanne, G.N. Thalmann, E. Veskim\u00e4e, M.J. Ribal, A.G. van der Heijden, European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines, European urology 79(1) (2021) 82-104.","DOI":"10.1016\/j.eururo.2020.03.055"},{"key":"10.1016\/j.bcp.2024.116125_b0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JEP.S267383","article-title":"Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy","volume":"13","author":"Tchounwou","year":"2021","journal-title":"J. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116125_b0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/14786410701192827","article-title":"Comparison of the sedative and hypnotic effects of flavonoids, saponins, and polysaccharides extracted from semen ziziphus jujube","volume":"21","author":"Jiang","year":"2007","journal-title":"Nat. Prod. Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116125_b0055","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/jf405820v","article-title":"Hydroxytyrosol and its potential therapeutic effects","volume":"62","author":"Hu","year":"2014","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116125_b0060","first-page":"11","article-title":"Pharmacology of a new alkaloid securinine","volume":"19","author":"IaA","year":"1956","journal-title":"Farmakol. Toksikol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116125_b0065","first-page":"2126","article-title":"Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells, FASEB journal : official publication of the Federation of American Societies for","volume":"24","author":"Rana","year":"2010","journal-title":"Exp. Biol."},{"key":"10.1016\/j.bcp.2024.116125_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8302636","article-title":"Anti-inflammatory and neuroprotective role of natural product securinine in activated glial cells: implications for parkinson's disease","volume":"2017","author":"Leonoudakis","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.bcp.2024.116125_b0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2006-960985","article-title":"Antimalarial compounds containing an alpha, beta-unsaturated carbonyl moiety from tanzanian medicinal plants","volume":"56","author":"Weenen","year":"1990","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.exppara.2010.09.002","article-title":"Toxoplasma gondii: inhibitory activity and encystation effect of securinine and pyrrolidine derivatives on toxoplasma growth","volume":"127","author":"Holmes","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-8741(90)90069-6","article-title":"Antibacterial activity of the leaves of Phyllanthus discoideus","volume":"28","author":"Mensah","year":"1990","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4489\/MYCO.2008.36.2.099","article-title":"Antifungal activity of securinine against some plant pathogenic fungi","volume":"36","author":"Singh","year":"2008","journal-title":"Mycobiology"},{"issue":"6","key":"10.1016\/j.bcp.2024.116125_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021203","article-title":"Securinine, a myeloid differentiation agent with therapeutic potential for AML","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116125_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120105","article-title":"Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: a possible mechanistic basis for its anticancer activity","volume":"287","author":"Ashraf","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2024.116125_b0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"19\u201320","key":"10.1016\/j.bcp.2024.116125_b0110","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.cca.2011.06.003","article-title":"Gastric cancer - the role of matrix metalloproteinases in tumor progression","volume":"412","author":"Lukaszewicz-Zaj\u0105c","year":"2011","journal-title":"Clinica Chimica Acta; Int. J. Clinical Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccr.2007.01.009","article-title":"A radical role for p38 MAPK in tumor initiation","volume":"11","author":"Kennedy","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/14756366.2020.1720013","article-title":"Selective inhibitors for JNK signalling: a potential targeted therapy in cancer","volume":"35","author":"Wu","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","article-title":"Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy","volume":"273","author":"Luo","year":"2009","journal-title":"Cancer Lett."},{"issue":"6859","key":"10.1016\/j.bcp.2024.116125_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2024.116125_b0135","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0140","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/path.3022","article-title":"The cell cycle and cancer","volume":"226","author":"Williams","year":"2012","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.bcp.2024.116125_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136923","article-title":"The influence of cell cycle regulation on chemotherapy","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116125_b0155","first-page":"3195","article-title":"The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells","volume":"34","author":"Namima","year":"2020","journal-title":"In Vivo (athens, Greece)"},{"issue":"6","key":"10.1016\/j.bcp.2024.116125_b0160","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.3892\/ol.2016.5288","article-title":"Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2024.116125_b0165","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1158\/0008-5472.CAN-15-2104","article-title":"Cell cycle-dependent mechanisms underlie vincristine-induced death of primary acute lymphoblastic leukemia cells","volume":"76","author":"Kothari","year":"2016","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2024.116125_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165372","article-title":"Securinine from Phyllanthus glaucus induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells","volume":"11","author":"Stefanowicz-Hajduk","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2024.116125_b0175","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1080\/01635581.2021.1925710","article-title":"Securinine induces differentiation of human promyelocytic leukemic HL-60 cells through JNK-mediated signaling pathway","volume":"74","author":"Sharma","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2024.116125_b0180","first-page":"267","article-title":"Regulation of inflammatory responses by MAPK signal transduction pathways","volume":"52","author":"Jiang","year":"2000","journal-title":"Sheng Li Xue Bao : [acta Physiologica Sinica]"},{"issue":"29","key":"10.1016\/j.bcp.2024.116125_b0185","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1016\/j.febslet.2005.10.064","article-title":"Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells","volume":"579","author":"Teraishi","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2004.02.017","article-title":"Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells","volume":"316","author":"Habiro","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116125_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106760","article-title":"Echinatin inhibits the growth and metastasis of human osteosarcoma cells through wnt\/\u03b2-catenin and p38 signaling pathways","volume":"191","author":"Lu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116125_b0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3892\/ijmm.2016.2676","article-title":"Curcumin exerts antitumor effects in retinoblastoma cells by regulating the JNK and p38 MAPK pathways","volume":"38","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2024.116125_b0205","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2024.116125_b0210","doi-asserted-by":"crossref","DOI":"10.1242\/dev.165902","article-title":"Wnt signalling: conquering complexity","volume":"145","author":"Wiese","year":"2018","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0215","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.18632\/aging.102698","article-title":"Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via wnt\/\u03b2-catenin pathway","volume":"12","author":"Liao","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0220","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1038\/s41598-017-09239-5","article-title":"In vivo regulation of glycogen synthase kinase 3\u03b2 activity in neurons and brains","volume":"7","author":"Krishnankutty","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2024.116125_b0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v8.i5.83","article-title":"WNT\/\u0392-catenin signaling in urothelial carcinoma of bladder","volume":"8","author":"Garg","year":"2019","journal-title":"World Journal of Nephrology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13880209.2019.1626449","article-title":"Qici sanling decoction suppresses bladder cancer growth by inhibiting the Wnt\/\u0392-catenin pathway","volume":"57","author":"Gong","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bcp.2024.116125_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109022","article-title":"Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the wnt\/\u03b2-catenin signaling pathway","volume":"320","author":"Zhang","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10286020.2017.1329828","article-title":"Secreted frizzled-related protein 1 (SFRP1) gene methylation changes in the human lung adenocarcinoma cells treated with L-securinine","volume":"20","author":"Yang","year":"2018","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"11","key":"10.1016\/j.bcp.2024.116125_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100785","article-title":"Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: a multi-center real-world retrospective study","volume":"3","author":"Hu","year":"2022","journal-title":"Cell Reports. Medicine"},{"issue":"18","key":"10.1016\/j.bcp.2024.116125_b0250","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.21.02051","article-title":"Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER trial","volume":"40","author":"Pfister","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116125_b0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.critrevonc.2015.05.005","article-title":"Emerging concepts on drug resistance in bladder cancer: implications for future strategies","volume":"96","author":"Massari","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116125_b0260","first-page":"2043","article-title":"Synergism inhibition of curcumin combined with cisplatin on T24 bladder carcinoma cells and its related mechanism","volume":"37","author":"Zhang","year":"2014","journal-title":"Zhong Yao Cai = Zhongyaocai = J. Chinese Med. Mater."},{"issue":"39","key":"10.1016\/j.bcp.2024.116125_b0265","doi-asserted-by":"crossref","first-page":"63870","DOI":"10.18632\/oncotarget.11563","article-title":"Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1\/2","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bcp.2024.116125_b0270","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.gendis.2023.03.031","article-title":"Echinatin inhibits tumor growth and synergizes with chemotherapeutic agents against human bladder cancer cells by activating p38 and suppressing wnt\/\u03b2-catenin pathways","volume":"11","author":"Wang","year":"2023","journal-title":"Genes & Diseases"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T20:21:40Z","timestamp":1728937300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":54,"alternative-id":["S0006295224001084"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116125","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Securinine inhibits the tumor growth of human bladder cancer cells by suppressing Wnt\/\u03b2-catenin signaling pathway and activating p38 and JNK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116125"}}